Roche’s new AAN 2020 data Event
Roche has hosted a live audio webcast and conference call on Tuesday, 28 April 2020.
| Agenda: | |
|---|---|
| Welcome | Karl Mahler, Head of Investor Relations and Roche Group Planning |
| Risdiplam: FIREFISH part 2 efficacy and safety in infants with type 1 SMA | Prof. Laurent Servais, MDUK Oxford Neuromuscular Center, Department of Paediatrics, University of Oxford, UK |
| Risdiplam: Update on clinical development program | |
| OCREVUS: Long-term data on key markers of disability progression in MS Shorter infusion (ENSEMBLE PLUS) data and regulatory update | Paulo Fontoura, M.D. Ph.D., Global Head Neuroscience and Rare Diseases Clinical Development |
| Q&A |
Webinar Replay
Investors